Cargando…
Hilar cholangiocarcinoma associated with immunoglobulin G4‐positive plasma cells and elevated serum immunoglobulin G4 levels
Immunoglobulin G4 (IgG4)‐related disease is a fibroinflammatory systemic disorder with multiorgan involvement. Proximal bile duct involvement results in IgG4‐related sclerosing cholangitis, which is characterized by a lymphoplasmacytic infiltrate with abundant IgG4‐positive plasma cells and fibrosis...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5880190/ https://www.ncbi.nlm.nih.gov/pubmed/29619414 http://dx.doi.org/10.1002/hep4.1164 |
_version_ | 1783311121843748864 |
---|---|
author | Azeem, Nabeel Ajmera, Veeral Hameed, Bilal Mehta, Neil |
author_facet | Azeem, Nabeel Ajmera, Veeral Hameed, Bilal Mehta, Neil |
author_sort | Azeem, Nabeel |
collection | PubMed |
description | Immunoglobulin G4 (IgG4)‐related disease is a fibroinflammatory systemic disorder with multiorgan involvement. Proximal bile duct involvement results in IgG4‐related sclerosing cholangitis, which is characterized by a lymphoplasmacytic infiltrate with abundant IgG4‐positive plasma cells and fibrosis. Differentiating between cholangiocarcinoma and IgG4‐sclerosing cholangitis can present a diagnostic dilemma. We describe an unusual presentation of a hepatic mass meeting multiple criteria for IgG4‐sclerosing cholangitis but was ultimately found to be cholangiocarcinoma. Several published case reports describe patients with suspected cholangiocarcinoma who are later found to have IgG4‐sclerosing cholangitis, but few reports have demonstrated the reverse. Distinguishing between cholangiocarcinoma and IgG4‐sclerosing cholangitis is challenging, and a high clinical suspicion for cholangiocarcinoma must always be maintained. (Hepatology Communications 2018;2:349‐353) |
format | Online Article Text |
id | pubmed-5880190 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-58801902018-04-04 Hilar cholangiocarcinoma associated with immunoglobulin G4‐positive plasma cells and elevated serum immunoglobulin G4 levels Azeem, Nabeel Ajmera, Veeral Hameed, Bilal Mehta, Neil Hepatol Commun Brief Report Immunoglobulin G4 (IgG4)‐related disease is a fibroinflammatory systemic disorder with multiorgan involvement. Proximal bile duct involvement results in IgG4‐related sclerosing cholangitis, which is characterized by a lymphoplasmacytic infiltrate with abundant IgG4‐positive plasma cells and fibrosis. Differentiating between cholangiocarcinoma and IgG4‐sclerosing cholangitis can present a diagnostic dilemma. We describe an unusual presentation of a hepatic mass meeting multiple criteria for IgG4‐sclerosing cholangitis but was ultimately found to be cholangiocarcinoma. Several published case reports describe patients with suspected cholangiocarcinoma who are later found to have IgG4‐sclerosing cholangitis, but few reports have demonstrated the reverse. Distinguishing between cholangiocarcinoma and IgG4‐sclerosing cholangitis is challenging, and a high clinical suspicion for cholangiocarcinoma must always be maintained. (Hepatology Communications 2018;2:349‐353) John Wiley and Sons Inc. 2018-02-28 /pmc/articles/PMC5880190/ /pubmed/29619414 http://dx.doi.org/10.1002/hep4.1164 Text en © 2018 The Authors. Hepatology Communications published by Wiley Periodicals, Inc., on behalf of the American Association for the Study of Liver Diseases. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Brief Report Azeem, Nabeel Ajmera, Veeral Hameed, Bilal Mehta, Neil Hilar cholangiocarcinoma associated with immunoglobulin G4‐positive plasma cells and elevated serum immunoglobulin G4 levels |
title | Hilar cholangiocarcinoma associated with immunoglobulin G4‐positive plasma cells and elevated serum immunoglobulin G4 levels |
title_full | Hilar cholangiocarcinoma associated with immunoglobulin G4‐positive plasma cells and elevated serum immunoglobulin G4 levels |
title_fullStr | Hilar cholangiocarcinoma associated with immunoglobulin G4‐positive plasma cells and elevated serum immunoglobulin G4 levels |
title_full_unstemmed | Hilar cholangiocarcinoma associated with immunoglobulin G4‐positive plasma cells and elevated serum immunoglobulin G4 levels |
title_short | Hilar cholangiocarcinoma associated with immunoglobulin G4‐positive plasma cells and elevated serum immunoglobulin G4 levels |
title_sort | hilar cholangiocarcinoma associated with immunoglobulin g4‐positive plasma cells and elevated serum immunoglobulin g4 levels |
topic | Brief Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5880190/ https://www.ncbi.nlm.nih.gov/pubmed/29619414 http://dx.doi.org/10.1002/hep4.1164 |
work_keys_str_mv | AT azeemnabeel hilarcholangiocarcinomaassociatedwithimmunoglobuling4positiveplasmacellsandelevatedserumimmunoglobuling4levels AT ajmeraveeral hilarcholangiocarcinomaassociatedwithimmunoglobuling4positiveplasmacellsandelevatedserumimmunoglobuling4levels AT hameedbilal hilarcholangiocarcinomaassociatedwithimmunoglobuling4positiveplasmacellsandelevatedserumimmunoglobuling4levels AT mehtaneil hilarcholangiocarcinomaassociatedwithimmunoglobuling4positiveplasmacellsandelevatedserumimmunoglobuling4levels |